Navigation Links
Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia,Clinical Trial

nd a broader range of activity than macrolides against Gram-positive bacteria associated with respiratory tract infections, and, again in in vitro tests, it appears to be effective against penicillin- and macrolide-resistant bacteria. Cethromycin has a mechanism of action that may slow the onset of future bacterial resistance. In addition to its utility in CAP, cethromycin has also been shown to be effective in animal studies for the prophylactic treatment of inhalation anthrax post exposure. The FDA has designated cethromycin as an orphan drug for the prophylactic treatment of inhalation anthrax post exposure, but the FDA has not yet approved the drug for marketing in this or any other indication.

About Advanced Life Sciences

Advanced Life Sciences is a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, cancer and inflammation. The Company's lead candidate, cethromycin, is a novel once-a-day antibiotic in late-stage clinical development for the treatment of respiratory tract infections including CAP. For more information, please visit us on the web at http://www.advancedlifesciences.com.

Forward-Looking Statements

Any statements contained in this press release that relate to future plans, events or performance are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, among others, those relating to technology and product development, clinical trials, market acceptance, government regulation and regulatory approval processes, intellectual property rights and litigation, dependence on collaborative relationshi
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycins First of Two Phase 3 Pneumonia Trials
2. Cethromycin Shown Effective Against Anthrax in Study
3. Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure Reduction During Important Early Morning Period When Most Adverse Cardiovascular Events Occur
4. Ontak (denileukin diftitox) Achieves 49.1% Overall Response Rate in Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL)
5. Micromet Achieves Milestone in BiTE Research Collaboration with MedImmune
6. Addex Achieves Statistically Significant Outcome in Phase IIa Clinical Trial With ADX10059 in Gastro-Esophageal Reflux Disease
7. Vicals Vaxfectin Adjuvant Achieves Dose-Sparing Effect With Seasonal Influenza Vaccine
8. Mymetics HIV Vaccine Achieves Research Breakthrough, Eliciting Protective Antibody Response in Mucosal Tissues of Non-Human Primate Model
9. Integrated Biopharmas Proprietary Vaccine Technology Achieves Strong Positive Results
10. Integrated BioPharmas Proprietary Vaccine Technology Achieves Strong Positive Results
11. ENDEAVOR IV Clinical Trial Meets Primary Endpoint
Post Your Comments:
(Date:5/15/2008)...nt of research reflects depth and breadth of, col... new treatments for diverse...impact of Zometa(R), the leading IV, bisphosphonat...east cancer, - Four oral sessions to feature RAD0... mTOR, including first results of RECORD-1 study i...
(Date:5/15/2008)...OULOUSE, France, May 15 /- Cerenis,Th...utical company,developing HDL-related compounds fo...seases, today announced that it has completed a Ph...ny,s lead product candidates.,CER-002 is a peroxis...pecific agonist in development for the treatment o...
(Date:5/15/2008)...emains for an Antiplatelet Therapy that, Combined,...nation of Plavix/Iscover and Aspirin, Accordin...M, Mass., May 15 /- Decision Resource...y firms for pharmaceutical and,healthcare issues, ...rs,improvement in patient compared to Sanofi-Avent...
(Date:5/15/2008)...5 /- Omega 3 fatty acids bound to,pho...credible natural,alternative and may have benefici...in vivo French study reveals. While several studie...yperactivity, French researchers have,hypothesized...fects on,impulse control., These research finding...
Breaking Medicine Technology:Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 2Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 3Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 4Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 5Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 6Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 7Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 8Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 9Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 10Cerenis Therapeutics Completes Phase I Clinical Trial of CER-002 for Treatment of Cardiovascular Disease 2Daiichi Sankyo/Eli Lilly's Effient and Astrazeneca's Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction 2Daiichi Sankyo/Eli Lilly's Effient and Astrazeneca's Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction 3Omega 3 Fatty Acids Bound to Phospholipids has Potential Benefit for Attention-Deficit Hyperactivity Disorder (ADHD) 2Omega 3 Fatty Acids Bound to Phospholipids has Potential Benefit for Attention-Deficit Hyperactivity Disorder (ADHD) 3Amicus Therapeutics to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference 1881 1Amicus Therapeutics to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference 1881 2Amicus Therapeutics to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference 1881 3Scientists uncover how the brain controls what the eyes see 6749 1Scientists uncover how the brain controls what the eyes see 6749 2Obesity associated with lower PSA levels in men with prostate cancer 6747 1Obesity associated with lower PSA levels in men with prostate cancer 6747 2PET Scans Can Spot Cervical Cancers Return 6744 1PET Scans Can Spot Cervical Cancers Return 6744 2
(Date:5/16/2008)... the lining of the uterus (submucosal) are more li...ne artery embolization (UAE) but usually dont caus..., The study included 49 patients with 140 fibroi...er UAE. The study found that 39 of these were subm...cavity after UAE, said Sachit Verma, MD, lead auth...
(Date:5/16/2008)...ise $38 Million for Life-threatening,Disease, BET...ers in nearly,every state will raise funds for cys...articipating in GREAT STRIDES, the largest nationa...nnounced today., May is National Cystic Fibrosis ...ning genetic disease that causes fatal lung infect...
(Date:5/16/2008)...ational HIV Vaccine Awareness Day, May,18, WASHIN... years into the,AIDS epidemic, someone is newly in...nday, May 18, HIV Vaccine Awareness Day, AIDS Acti...Institute of Allergy and Infectious,Disease (NIAID... everyone,to help end the AIDS epidemic by partici...
(Date:5/16/2008)...re-USNewswire/ -- Emergency Medical,Services Week,...edication,of Pennsylvania,s first responders and e...teers, according to state Secretary of Health Dr. ...fe is Our Mission," emphasizes that no,matter what...to provide,immediate, life-saving care and transpo...
Breaking Medicine News(10 mins):Health News:GREAT STRIDES Walks for Cystic Fibrosis Slated for 47 States This Weekend 2Health News:AIDS Action Urges Everyone to Help End the AIDS Epidemic by Being Part of the Search for an HIV Vaccine 2Health News:PA Secretary of Health Announces 'Emergency Medical Services Week,' May 18 - 24 2
... death toll in the fake drug case in China has sho...heck on pharmaceutical companies//, the state medi...dead from using the fake Armillarisni A injection ...ical Co Ltd, said officials with the Third Hospita...
... U.S. Food and Drug Administration authority is un...y contraception drug as an over-the counter drug//...he FDA has been urged to take an independent, non-...euticals Inc's bid to sell its morning after pill ...
... persons were arrested for allegedly selling fake ...CPMT), which was held at 137 centres across// 17 d...rsons were arrested in Allahabad and another perso... CPMT question papers, which later turned out to b...
...tland: This ain’t funny, but drugs seem to hold ma...ed the alarming rise of drugs among youngsters,// ... labour has come to power. Experts have reiterate... remedy this menace, among children. Neil McKegane...
Other Medicine News:
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
Medicine Products: